Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Non-Current Assets (2016 - 2026)

Healthstream has reported Non-Current Assets over the past 16 years, most recently at $400.7 million for Q4 2025.

  • Quarterly Non-Current Assets rose 12.04% to $400.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 1.64% year-over-year, with the annual reading at $400.7 million for FY2025, 12.04% up from the prior year.
  • Non-Current Assets was $400.7 million for Q4 2025 at Healthstream, up from $352.4 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $400.7 million in Q4 2025 and troughed at $352.4 million in Q3 2025.
  • The 5-year median for Non-Current Assets is $376.1 million (2022), against an average of $372.6 million.
  • Year-over-year, Non-Current Assets skyrocketed 37.84% in 2021 and then fell 4.0% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $379.9 million in 2021, then increased by 0.91% to $383.4 million in 2022, then fell by 3.56% to $369.7 million in 2023, then decreased by 3.27% to $357.6 million in 2024, then grew by 12.04% to $400.7 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Non-Current Assets are $400.7 million (Q4 2025), $352.4 million (Q3 2025), and $355.8 million (Q2 2025).